Lv21
116 积分 2025-10-15 加入
Expanding Bevacizumab-Erlotinib Therapy Through Fumarate Hydratase Deficiency Screening and Drug Target Pathway Analysis in Papillary Morphology Metastatic Renal Cell Carcinoma
1小时前
求助中
Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?
4天前
已关闭
A randomized phase 2 trial of nivolumab, relatlimab plus ipilimumab vs. nivolumab plus ipilimumab in first-line advanced renal cell carcinoma
4天前
已关闭
Preclinical and First-in-Human Study of Carbonic Anhydrase IX–Targeting Theranostic Pair, [ 68 Ga]Ga/[ 177 Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma
24天前
已完结
Spatial Multiomic Analyses Reveal Carcinogenic Pathways in End-Stage Renal Disease
2个月前
已完结
Inflammation-Driven Field Cancerization in End-Stage Kidney Disease
2个月前
已完结
Inflammation-Driven Field Cancerization in End-Stage Kidney Disease
2个月前
已关闭
The Hippo Pathway is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1 Resistant Cancer
2个月前
已关闭
LASER: A Phase 2 Trial of 177 Lu-PSMA-617 as Systemic Therapy for RCC
3个月前
已关闭
Performance of 99m Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical Experience
4个月前
已关闭
皖公网安备34019202002308
